Search

everythinglearnresearchcommunity

for

Search:↓

Researchers found that most genes affecting drug responses are not fully covered by commercial SNP chips, suggesting the need for more comprehensive tools to optimize drug selection based on genetics.

A baby boy with 13q deletion syndrome had eye cancer, a woman's vision improved after stopping a breast cancer drug, a man developed cataracts from using Propecia, and a rare skin disorder called Lipoid Proteinosis was discussed. Also, a tool called OCT is useful for diagnosing macular diseases.

Minoxidil effectively promotes hair regrowth in younger patients with small balding areas.

Some skin diseases and their treatments can negatively affect male fertility.

Negative expectations can cause adverse effects in dermatology treatments, like with finasteride for baldness, and careful communication can help reduce these nocebo responses.

No definitive link between finasteride and male breast cancer, but further research is needed.

Finasteride helped treat a 28-year-old's facial skin condition.

Male hormones control a specific gene in hamster skin, with different hormones having varying effects.

A new method accurately measures steroid hormones in a few hair strands and could help study chronic stress and hair loss.

Some men taking finasteride for hair loss may experience sexual problems like erectile dysfunction and decreased sex drive, which can persist even after stopping the medication.

Stromal Vascular Fraction might help with male sexual dysfunction, but more research is needed to confirm its safety and effectiveness.

Nandrolone might increase muscle mass with fewer side effects than testosterone but could cause erectile dysfunction and needs more research.

Finasteride affects brain stress and enzyme activity differently in various regions, possibly helping with liver-related brain issues.

The conclusion suggests a new way to classify bradykinin-mediated angio-oedema based on different causes and its possible link with urticaria, which could improve diagnosis and treatment.

Taking Propecia might lead to the development of cataracts.

Skin reactions to drugs are common and can be deadly, usually requiring stopping the drug and may be better prevented with genetic testing in the future.

Drugmakers are optimistic about targeting the Wnt pathway for new treatments despite past challenges.

Certain spices may help prevent and treat skin cancer, but more human trials are needed.

The document concludes that proper diagnosis and evidence-based treatments are crucial for managing hair diseases, and psychological support for patients is important.

A high dietary antioxidant index may lower the risk of various diseases, but more research is needed.

Glypican-1 is important for blood vessel growth in hair follicles and could help treat hair loss.

A combination of nanomilled oral testosterone and dutasteride normalized testosterone levels in men with low testosterone and is safe for short-term use.

Colorectal cancer's ability to spread is due to changes in many genes, not just one.

Young men's sexual dysfunction often has physical causes, which can lead to stress and worsen the problem.

Nanotechnology is improving drug delivery and targeting, with promising applications in cancer treatment, gene therapy, and cosmetics, but challenges remain in ensuring precise delivery and safety.

Microemulsions could improve how drugs are delivered and absorbed in the body.

The document discusses various eye conditions and their treatments, including a rare eye cancer in a baby, vision loss from a cancer drug, cataracts from a baldness treatment, a rare skin disorder, and a specific type of eye disease diagnosed with a special imaging technique.

The document concludes that fexofenadine reduces inflammation in chronic hives, cholestyramine helps half of pregnant women with itchy rashes, and relaxing incisions are a good alternative in facial surgery for the elderly.

The document concludes that treating androgen excess needs patience, managing expectations is important, and many drugs used are not officially approved, suggesting cosmetic options for mild cases.

Ruxolitinib treatment may cause eyelash growth.